Selected article for: "adverse reaction and CQ treat"

Author: Krishan Mohan Kapoor; Aanandita Kapoor
Title: Role of Chloroquine and Hydroxychloroquine in the Treatment of COVID-19 Infection- A Systematic Literature Review
  • Document date: 2020_3_30
  • ID: 0lk8eujq_32
    Snippet: There are some mild side effects of CQ while treating malaria, including headache, dizziness, loss of appetite, etc. The primary adverse reaction of CQ at higher doses is ocular toxicity, which could affect the vision. If the discomfort in the eye or visual abnormality occurs, CQ should be discontinued immediately. Other side effects of CQ include cardiac arrhythmia, drug-induced psychosis, leukopenia, etc. Combining CQ with heparin could increas.....
    Document: There are some mild side effects of CQ while treating malaria, including headache, dizziness, loss of appetite, etc. The primary adverse reaction of CQ at higher doses is ocular toxicity, which could affect the vision. If the discomfort in the eye or visual abnormality occurs, CQ should be discontinued immediately. Other side effects of CQ include cardiac arrhythmia, drug-induced psychosis, leukopenia, etc. Combining CQ with heparin could increase the risk of bleeding. In patients taking Digitalis, CQ could cause a cardiac block. 13 For decades, most Europeans visiting malaria-endemic areas have been receiving chloroquine prophylaxis, and they would continue it for two months after their return. The use of CQ for the treatment of malaria has also been in use for long, and HCQ has been used at much higher doses of up to 600 mg/day to treat autoimmune diseases. It is quite difficult to find a product having a betterestablished safety profile than CQ at such a low cost. 10 CQ, and its derivatives have shown early promise to treat COVID-19 infection and should be explored as a potential drug in the preventive and therapeutic role to turn the tide in this rapidly evolving pandemic. 25 Disorderly clinical trials of All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • adverse reaction and clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • adverse reaction and drug induce: 1, 2
    • adverse reaction and high dose: 1, 2, 3, 4, 5, 6, 7, 8
    • adverse reaction and infection treat: 1
    • adverse reaction and low cost: 1
    • adverse reaction and malaria treatment: 1
    • adverse reaction and mg day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • adverse reaction and potential drug: 1, 2, 3, 4
    • adverse reaction and safety profile: 1, 2, 3, 4, 5, 6
    • appetite loss and clinical trial: 1, 2, 3, 4, 5
    • appetite loss and infection treat: 1
    • appetite loss and malaria endemic: 1
    • appetite loss and mg day: 1
    • autoimmune disease and cardiac arrhythmia: 1
    • autoimmune disease and clinical trial: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • autoimmune disease and early promise: 1
    • autoimmune disease and high dose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • autoimmune disease and infection treat: 1, 2, 3, 4
    • autoimmune disease and low cost: 1, 2, 3, 4, 5